HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Anas Younes Selected Research

N- (2- aminophenyl)- 4- ((4- pyridin- 3- ylpyrimidin- 2- ylamino)methyl)benzamide

6/2011Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor.
11/2010The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Anas Younes Research Topics

Disease

65Hodgkin Disease (Hodgkin's Disease)
06/2014 - 01/2002
45Neoplasms (Cancer)
08/2014 - 03/2002
40Lymphoma (Lymphomas)
10/2014 - 12/2002
28Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2014 - 09/2003
11Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2012 - 12/2003
9Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2014 - 12/2003
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
08/2014 - 11/2010
6B-Cell Lymphoma (Lymphoma, B Cell)
04/2014 - 08/2003
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2012 - 03/2003
5Disease Progression
07/2012 - 03/2004
5Necrosis
03/2011 - 08/2003
4Infection
12/2013 - 04/2005
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2014 - 05/2012
3Neutropenia
12/2013 - 07/2005
3Hematologic Neoplasms (Hematological Malignancy)
11/2012 - 02/2008
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2012 - 10/2004
3Leukemia
02/2012 - 10/2004
2Anemia
12/2013 - 07/2005
2Thrombocytopenia (Thrombopenia)
12/2013 - 11/2010
2Fatigue
12/2013 - 12/2013
2Testicular Neoplasms (Testicular Cancer)
11/2011 - 10/2011
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2010 - 09/2010
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2004 - 08/2004
1Dyspnea (Shortness of Breath)
12/2013
1Syncope (Fainting)
12/2013
1Pulmonary Embolism
12/2013

Drug/Important Bio-Agent (IBA)

17rituximab (Mabthera)FDA Link
10/2014 - 07/2003
13cAC10-vcMMAEIBA
10/2014 - 11/2010
12Doxorubicin (Adriamycin)FDA LinkGeneric
08/2014 - 12/2004
6Prednisone (Sone)FDA LinkGeneric
08/2014 - 12/2004
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2014 - 12/2004
6Vincristine (Oncovin)FDA LinkGeneric
08/2014 - 12/2004
6LBH589IBA
05/2014 - 09/2010
6Bleomycin (Blenoxane)FDA LinkGeneric
04/2014 - 11/2006
6fludarabineIBA
03/2012 - 12/2002
6Histone Deacetylase InhibitorsIBA
12/2011 - 09/2010
5CytokinesIBA
05/2014 - 01/2005
5Dacarbazine (DIC)FDA LinkGeneric
04/2014 - 11/2006
5vorinostat (suberoylanilide hydroxamic acid)FDA Link
07/2013 - 04/2008
5Monoclonal AntibodiesIBA
09/2012 - 08/2005
517-(allylamino)-17-demethoxygeldanamycin (17AAG)IBA
05/2012 - 04/2005
5bortezomib (Velcade)FDA Link
07/2011 - 05/2004
5Proteins (Proteins, Gene)IBA
11/2010 - 08/2003
5Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2007 - 04/2005
4Methotrexate (Mexate)FDA LinkGeneric
12/2013 - 12/2003
4Cytarabine (Cytosar-U)FDA LinkGeneric
12/2013 - 04/2005
4AntigensIBA
08/2012 - 01/2007
4Vinblastine (Vinblastine Sulfate)FDA Link
05/2012 - 11/2006
4Sirolimus (Rapamycin)FDA Link
11/2010 - 01/2006
4Proteasome Endopeptidase Complex (Proteasome)IBA
11/2010 - 05/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2008 - 08/2003
4AntibodiesIBA
01/2007 - 08/2005
4Phosphotransferases (Kinase)IBA
02/2006 - 08/2003
3Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 03/2006
3Dexamethasone (Maxidex)FDA LinkGeneric
12/2013 - 12/2002
3InterferonsIBA
05/2012 - 07/2005
3gemcitabineFDA Link
03/2012 - 02/2008
3Melphalan (Alkeran)FDA LinkGeneric
03/2012 - 04/2005
3temsirolimusFDA Link
11/2010 - 04/2008
3galiximabIBA
01/2007 - 03/2003
3NF-kappa B (NF-kB)IBA
05/2004 - 01/2002
2Topotecan (Hycamtin)FDA LinkGeneric
10/2014 - 03/2006
2ChemokinesIBA
05/2014 - 10/2011
2Chemokine CCL17IBA
05/2014 - 10/2011
2everolimusFDA Link
12/2013 - 04/2012
2EnzymesIBA
01/2013 - 11/2009
2Immunoconjugates (Immunoconjugate)IBA
08/2012 - 01/2007
2Adenosine Triphosphate (ATP)IBA
07/2012 - 01/2012
2A-factor (Streptomyces)IBA
07/2012 - 08/2003
2N 30IBA
10/2011 - 03/2002
2N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)IBA
10/2011 - 09/2010
2Interleukin-12 (IL 12)IBA
10/2011 - 08/2004
2N- (2- aminophenyl)- 4- ((4- pyridin- 3- ylpyrimidin- 2- ylamino)methyl)benzamideIBA
06/2011 - 11/2010
2Interleukin-10 (Interleukin 10)IBA
03/2011 - 08/2008
2romidepsin (FK228)FDA Link
11/2010 - 09/2010
2Cyclin D1IBA
04/2008 - 10/2006
2Etoposide (VP 16)FDA LinkGeneric
12/2007 - 04/2005
2RANK LigandIBA
10/2007 - 09/2003
2VaccinesIBA
01/2007 - 08/2004
2anaplastic lymphoma kinaseIBA
12/2006 - 12/2003
2U 0126 (UO 126)IBA
12/2006 - 08/2003
2pegfilgrastim (Neulasta)FDA Link
11/2006 - 03/2006
2TNF-Related Apoptosis-Inducing LigandIBA
03/2006 - 09/2003
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
03/2006 - 09/2003
2Caspase 8 (Caspase-8)IBA
08/2005 - 08/2003
2Mitoxantrone (Novantrone)FDA LinkGeneric
07/2005 - 12/2002
2LigandsIBA
10/2004 - 09/2003
2CD40 Ligand (CD40L)IBA
09/2003 - 01/2002
1PlatinumIBA
10/2014
1Biological Markers (Surrogate Marker)IBA
08/2014

Therapy/Procedure

27Drug Therapy (Chemotherapy)
10/2014 - 03/2002
18Stem Cell Transplantation
04/2014 - 12/2002
9Transplants (Transplant)
10/2014 - 02/2008
4Combination Drug Therapy (Combination Chemotherapy)
04/2014 - 09/2003
4Aftercare (After-Treatment)
12/2013 - 07/2005
3Radiotherapy
01/2003 - 03/2002
2Intravenous Infusions
08/2012 - 08/2005
2Homologous Transplantation (Allograft)
02/2008 - 12/2003
2Investigational Therapies (Experimental Therapy)
10/2005 - 08/2004
1Therapeutics
11/2013